# OnCo record crcdx-ras (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/crcdx-ras/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "crcdx-ras" ;
  schema:name "CRCDx RAS Mutation Detection Assay Kit"@en ;
  schema:description "A PCR test that confirms a bowel cancer has no KRAS or NRAS mutation before panitumumab."@en ;
  schema:url <https://onco.cc/drugs/crcdx-ras/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P220005>, <https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools>, <https://www.entrogen.com/> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "Real-time PCR companion diagnostic test (KRAS and NRAS, colorectal tumour tissue)" ;
  schema:alternateName "CRCdx RAS Mutation Detection" ;
  onco:approval "US 2023: KRAS and NRAS wild-type (exons 2, 3 and 4) for panitumumab in colorectal cancer" ;
  onco:related <https://onco.cc/biomarkers/ras-wild-type/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/kras/>, <https://onco.cc/targets/nras/> ;
  onco:drugs <https://onco.cc/drugs/panitumumab/> ;
  onco:companies <https://onco.cc/companies/entrogen/> ;
  onco:terms <https://onco.cc/terms/pcr/>, <https://onco.cc/terms/companion-diagnostic-term/> .